DDInter740 DDInter832
Flecainide is a Class I anti-arrhythmic agent like [encainide] and [propafenone]. Flecainide’s development began in 1966 and was first synthesized in 1972 as an attempt to generate new anesthetics. It is used to prevent supraventricular and ventricular arrhythmias, as well as paroxysmal atrial fibrillation and flutter.[L8878,L5056] Flecainide was granted FDA approval on 31 October 1985.
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
Flecainide {u} (Compound) resembles {v} (Compound) Mefloquine
Flecainide {u} (Compound) binds {v} (Gene) CYP2D6
Flecainide {u} (Compound) upregulates {v} (Gene) MTHFD2
Flecainide {u} (Compound) downregulates {v} (Gene) RRM2
Flecainide {u} (Compound) causes {v} (Side Effect) Shock
Flecainide (Compound) resembles Mefloquine (Compound)
Flecainide (Compound) binds CYP2D6 (Gene)
Flecainide (Compound) upregulates MTHFD2 (Gene)
Flecainide (Compound) downregulates RRM2 (Gene)
Flecainide (Compound) causes Shock (Side Effect)